Product Code: ETC4471648 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 | |
The cardiac marker testing market in Singapore is witnessing substantial growth as cardiovascular diseases remain a leading cause of morbidity and mortality in the country. Cardiac marker tests are essential for diagnosing heart-related conditions and monitoring patients with acute cardiac issues. With the introduction of high-sensitivity cardiac troponin assays and other advanced technologies, the market is poised for significant developments. The rising prevalence of risk factors such as obesity and diabetes, coupled with an aging population, is expected to drive the demand for cardiac marker testing in Singapore, making it a crucial aspect of the healthcare industry.
The Singapore Cardiac Marker Testing market is growing rapidly, driven by several critical factors. Cardiac marker testing plays a pivotal role in diagnosing and managing heart-related conditions, including myocardial infarction and heart failure. The increasing prevalence of cardiovascular diseases and risk factors in the population is fueling the demand for cardiac marker testing. Timely and accurate diagnosis is essential for better patient outcomes, and advancements in testing technologies contribute to the market`s growth. Furthermore, healthcare providers are increasingly incorporating cardiac marker tests into routine health check-ups and emergency department protocols, further boosting the market. Singapore focus on improving healthcare infrastructure and the quality of healthcare services ensures that cardiac marker testing remains an integral part of the healthcare system, contributing to better patient care and outcomes.
The Singapore Cardiac Marker Testing Market encounters challenges associated with early detection, patient education, and test accessibility. Cardiac markers play a crucial role in diagnosing heart-related conditions, but raising awareness about the importance of early detection remains a challenge. Ensuring that patients have access to cardiac marker testing and understand the significance of the results is crucial for improving patient outcomes. Additionally, developing new and more sensitive cardiac markers and improving the accuracy of existing tests is an ongoing challenge.
The COVID-19 pandemic impacted the Singapore cardiac marker testing market by creating awareness of the importance of cardiac biomarkers in diagnosing and monitoring heart-related conditions. Cardiac marker testing gained prominence in assessing cardiac health, especially in COVID-19 patients with cardiovascular complications. Healthcare providers recognized the value of cardiac biomarkers in risk assessment and patient management. The market experienced a growing demand for these tests and witnessed developments in more efficient and rapid testing methods.
Prominent players in the cardiac marker testing market include Abbott Laboratories, Siemens Healthineers, and bioM?rieux, offering diagnostic solutions for heart-related conditions.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Singapore Cardiac Marker Testing Market Overview |
3.1 Singapore Country Macro Economic Indicators |
3.2 Singapore Cardiac Marker Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Singapore Cardiac Marker Testing Market - Industry Life Cycle |
3.4 Singapore Cardiac Marker Testing Market - Porter's Five Forces |
3.5 Singapore Cardiac Marker Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Singapore Cardiac Marker Testing Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.7 Singapore Cardiac Marker Testing Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.8 Singapore Cardiac Marker Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Singapore Cardiac Marker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Singapore Cardiac Marker Testing Market Trends |
6 Singapore Cardiac Marker Testing Market, By Types |
6.1 Singapore Cardiac Marker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Singapore Cardiac Marker Testing Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Singapore Cardiac Marker Testing Market Revenues & Volume, By Reagents and Kits, 2021-2031F |
6.1.4 Singapore Cardiac Marker Testing Market Revenues & Volume, By Instruments, 2021-2031F |
6.2 Singapore Cardiac Marker Testing Market, By Biomarker Type |
6.2.1 Overview and Analysis |
6.2.2 Singapore Cardiac Marker Testing Market Revenues & Volume, By Troponin I and T, 2021-2031F |
6.2.3 Singapore Cardiac Marker Testing Market Revenues & Volume, By Creatine kinase-MB(CK-MB), 2021-2031F |
6.2.4 Singapore Cardiac Marker Testing Market Revenues & Volume, By Natriuretic peptide (Bnp Or Nt-Probnp), 2021-2031F |
6.2.5 Singapore Cardiac Marker Testing Market Revenues & Volume, By Myoglobin, 2021-2031F |
6.2.6 Singapore Cardiac Marker Testing Market Revenues & Volume, By High-sensitivity C-reactive protein(hs-CRP), 2021-2031F |
6.2.7 Singapore Cardiac Marker Testing Market Revenues & Volume, By Other Cardiac Biomarkers, 2021-2031F |
6.3 Singapore Cardiac Marker Testing Market, By Disease |
6.3.1 Overview and Analysis |
6.3.2 Singapore Cardiac Marker Testing Market Revenues & Volume, By Myocardial Infarction, 2021-2031F |
6.3.3 Singapore Cardiac Marker Testing Market Revenues & Volume, By Congestive Heart Failure, 2021-2031F |
6.3.4 Singapore Cardiac Marker Testing Market Revenues & Volume, By Acute Coronary Syndrome, 2021-2031F |
6.3.5 Singapore Cardiac Marker Testing Market Revenues & Volume, By Atherosclerosis, 2021-2031F |
6.3.6 Singapore Cardiac Marker Testing Market Revenues & Volume, By Ischemia, 2021-2031F |
6.4 Singapore Cardiac Marker Testing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Singapore Cardiac Marker Testing Market Revenues & Volume, By Laboratory Testing Facilities, 2021-2031F |
6.4.3 Singapore Cardiac Marker Testing Market Revenues & Volume, By Point-Of-Care Testing Facilities, 2021-2031F |
6.4.4 Singapore Cardiac Marker Testing Market Revenues & Volume, By Academic Institutions, 2021-2031F |
7 Singapore Cardiac Marker Testing Market Import-Export Trade Statistics |
7.1 Singapore Cardiac Marker Testing Market Export to Major Countries |
7.2 Singapore Cardiac Marker Testing Market Imports from Major Countries |
8 Singapore Cardiac Marker Testing Market Key Performance Indicators |
9 Singapore Cardiac Marker Testing Market - Opportunity Assessment |
9.1 Singapore Cardiac Marker Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Singapore Cardiac Marker Testing Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.3 Singapore Cardiac Marker Testing Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.4 Singapore Cardiac Marker Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Singapore Cardiac Marker Testing Market - Competitive Landscape |
10.1 Singapore Cardiac Marker Testing Market Revenue Share, By Companies, 2024 |
10.2 Singapore Cardiac Marker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |